OVERVIEW

Autodisplay Biotech was founded in May 2008 as a spin-off from the Heinrich-Heine University Dusseldorf in Germany.

The management team consists of the three founders

• Dr. Ruth Maas, CEO
• Prof. Dr. Joachim Jose, CSO
• Dr. Gunter Festel, CFO/Head of Business Development

Core business is the development and out-licensing of own intellectual property (IP) as well as the production of selected biocatalysts and bioanalytical tools. Autodisplay Biotech also acts as a service provider in certain areas.

The company already has a strong intellectual property position in its core technology areas and some of the applications like biocatalysis and drug discovery are already or almost developed. Through co-operation agreements, Autodisplay Biotech's own patent situation is strengthened within fundamental technologies, enabling the focus on the application-oriented further development and commercialisation of the autodisplay technology.